Epstein-linked longevity expert Peter Attia is leaving David Broten, and his startup would not comment

The founder of David Protein, maker of high-protein nutrition bars, announced Monday that longevity expert Dr. Peter Attia “has resigned from his position as chief science officer at David.”

The announcement comes after Attia’s name appeared in more than 1,700 documents, including email correspondence, that were released on Friday as part of a massive dossier related to convicted sex offender Jeffrey Epstein, according to The New York Times. Attia worked on the food startup’s executive team and was also an early investor.

For those who don’t know him, Attia is an American-Canadian physician who has become one of the most prominent voices in the field of longevity and preventive health. He is best known for his best-selling book “Outlive: The Science and Art of Longevity” and his now seven-year-old podcast, where he explores improvement strategies. He was also named last month as a CBS contributor.

Three-year-old New York-based David Protein raised a $75 million Series A funding round in May last year led by Greenoaks, with participation from Valor Equity Partners. The company has seen significant growth since launching its flagship protein bar in September 2024, a product it describes as having 28 grams of protein, zero sugar, and 150 calories.

In a lengthy post on the website Attia also discussed at length how he came to know Epstein and why he remained involved with him even after Epstein’s 2008 conviction.

The ramifications appear to extend beyond David’s protein. It also appears that Biograph, the healthcare and longevity testing startup that Attia co-founded with entrepreneur John Herring, may be distancing itself from the doctor. The company declined to comment on Attia’s continued involvement with the startup or on the pages on its website that used to mention him but now delete his name or display a “File not found” error.

Biograph came out of obscurity a year ago, TechCrunch previously reported, with backing from investors that include Vy Capital, Human Capital, Alpha Wave, and WndrCo, along with angel investors, including Balaji Srinivasan. Like a growing number of medical services companies, Biograph offers premium preventive health services to subscribers who pay between $7,500 and $15,000 annually. Attia was previously mentioned in the company’s press release and website as a co-founder.